Skip to content

Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population

The Role of Remote Pharmacy Services With Continuous Glucose Monitoring in an Underserved Population

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07587151
Enrollment
46
Registered
2026-05-14
Start date
2025-03-31
Completion date
2026-04-28
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

diabetes, continuous glucose monitor, telehealth, federally qualified health center

Brief summary

The purpose of this study is to improve T2DM (type 2 diabetes mellitus) management and health outcomes among underserved patients who receive primary care at a federally qualified health center (FQHC) in Winnebago County, Illinois. Our aim is to assess the feasibility and preliminary effectiveness of a pilot program combining continuous glucose monitoring (CGM) with monthly telehealth appointments to improve diabetes management in FQHC patients who have uncontrolled T2DM (HbA1c \>7%). Researchers will compare those who receive the intervention (usual in-person care + CGM + 2 telehealth visits with a clinical pharmacist and family medicine resident) with those receiving a CGM in additional to usual care (in-person care + CGM). Participants will have their HbA1c tested and complete surveys to assess diabetes-related distress and diabetes management self-efficacy at baseline and 3 and 6 months from baseline. This will allow the investigators to raise glucose awareness for all participants utilizing CGM technology while simultaneously determining the necessity of more frequent follow-up than the guideline recommended intervals of 3 months for uncontrolled diabetes in an under-resourced population. This will also allow us to evaluate the feasibility of telehealth in delivering more frequent follow-up care to patients with T2DM.

Interventions

OTHERCGM plus telehealth

Participants will receive CGM supplies for 3 months plus 2 monthly telehealth appointments.

Participants will receive CGM supplies for 3 months

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient receiving primary care from the study clinical site * Uncontrolled T2DM (HbA1c \>7%) * 18 years of age and older

Exclusion criteria

* Patients younger than 18 years of age * Patients in correctional facilities * Pregnant or lactating women * Current Continuous Glucose Monitoring device (CGM) users * Patients with gestational diabetes mellitus or Type 1 diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
HbA1cEnrollment, 3 months, and 6 monthsHemoglobin A1c

Secondary

MeasureTime frameDescription
Diabetes-related distressEnrollment, 3 months, and 6 monthsDiabetes-related distress as assessed by the TYPE 2 DIABETES DISTRESS ASSESSMENT SYSTEM (T2-DDAS)
Diabetes Management Self-EfficacyBaseline, 3 months, and 6 monthsDiabetes management self-efficacy as assessed by the Stanford English Diabetes Self-Management study diabetes self-efficacy questionnaire. Stanford English Diabetes Self-Management study. Study reported in Lorig K, Ritter PL, Villa FJ, Armas J. Community-Based Peer-Led Diabetes Self-Management: A Randomized Trial. The Diabetes Educator 2009; Jul-Aug;35(4):641-51.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026